4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-15-000035
CEO bought 142,550 shares at an average $0.15 ($21,024)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-07-23 | Purchase : show line 1 in the form | +27,550 | $0.14 | $3,829 | 4,634,230 | D |
| 2015-07-23 | Purchase : show line 2 in the form | +10,000 | $0.14 | $1,400 | 4,644,230 | D |
| 2015-07-24 | Purchase : show line 3 in the form | +10,000 | $0.16 | $1,550 | 4,654,230 | D |
| 2015-07-24 | Purchase : show line 4 in the form | +25,000 | $0.15 | $3,750 | 4,679,230 | D |
| 2015-07-24 | Purchase : show line 5 in the form | +20,000 | $0.15 | $2,998 | 4,699,230 | D |
| 2015-07-24 | Purchase : show line 6 in the form | +5,000 | $0.15 | $750 | 4,704,230 | D |
| 2015-07-24 | Purchase : show line 7 in the form | +10,000 | $0.15 | $1,499 | 4,714,230 | D |
| 2015-07-24 | Purchase : show line 8 in the form | +5,000 | $0.15 | $750 | 4,719,230 | D |
| Open-market purchases · 142,550 sh · avg $0.15 · $21,024 | ||||||
Loading xslF345X03/primary_doc.xml…